Analyst Ratings For MGEN – Miragen Therapeutics (NASDAQ:MGEN)
Today, Cowen reiterated its Hold rating on MGEN – Miragen Therapeutics (NASDAQ:MGEN).
Some recent analyst ratings include
- 4/9/2018-Cowen Reiterated Rating of Hold.
- 3/29/2018-Jefferies Group initiated coverage with a Buy rating.
- 3/28/2018-Wedbush Reiterated Rating of Outperform.
- 3/22/2018-Deutsche Bank initiated coverage with a Buy rating.
- 3/9/2018-Evercore ISI initiated coverage with a Outperform rating.
- 2/2/2018-Cann Reiterated Rating of Buy.
- 1/16/2018-Chardan Capital Reiterated Rating of Buy.
Recent Insider Trading Activity For MGEN – Miragen Therapeutics (NASDAQ:MGEN)
MGEN – Miragen Therapeutics (NASDAQ:MGEN) has insider ownership of 44.40% and institutional ownership of 18.98%.
- On 2/13/2018 Adam Scott Levy, Insider, bought 9,090 with an average share price of $5.50 per share and the total transaction amounting to $49,995.00.
- On 2/13/2018 Bruce Booth, Director, bought 545,454 with an average share price of $5.50 per share and the total transaction amounting to $2,999,997.00.
- On 12/20/2017 Thomas E. Hughes, Director, sold 12,000 with an average share price of $8.00 per share and the total transaction amounting to $96,000.00.
- On 6/22/2017 Adam Scott Levy, Insider, bought 200 with an average share price of $7.55 per share and the total transaction amounting to $1,510.00.
- On 3/10/2017 Kyle Lefkoff, Director, sold 5,800 with an average share price of $14.34 per share and the total transaction amounting to $83,172.00.
- On 3/8/2017 Kyle Lefkoff, Director, sold 15,000 with an average share price of $15.40 per share and the total transaction amounting to $231,000.00.
- On 2/28/2017 Kyle Lefkoff, Director, sold 10,258 with an average share price of $13.89 per share and the total transaction amounting to $142,483.62.
Recent Trading Activity for MGEN – Miragen Therapeutics (NASDAQ:MGEN)
Shares of MGEN – Miragen Therapeutics closed the previous trading session at 6.48 down -0.02 0.31% with 6.579999923706055 shares trading hands.